The Breast Cancer Startup Challenge (BCSC) has truly been the greatest experience of my academic and professional career. I have been successful in many academic competitions in the past, however the BCSC has set up teams for success unlike any other competition. This first-of-its-kind competition stems from the brilliant mind Rosemarie Truman and her amazing team and colleagues at the National Cancer Institute (NCI). In addition to identifying the most promising technologies at the National Institutes of Health (NIH) and NCI Rosemarie has provided the services of herself and the entire Center for Advancing Innovation, to guarantee success.
Rosemarie’s vision and grit in this endeavor is truly unparalleled. She had the resources and the expertise to help any team get over any hurdle or obstacle. She made introductions, refined pitches, made important resources accessible, and recruited some of the most prominent industry partners to give each team every opportunity to succeed. It was amazing to see this kind of commitment because usually in any entrepreneurial endeavor is difficult to navigate and there can be a lot of uncertainty, but much of that was minimized with the help of Rosemarie and her team.
Going forward, we should all look forward to the foundation of many great startups from similar CAI and NIH Startup Challenges. These competitions explore all a previously untapped “treasure trove” of innovation to make an impact on human health. More than $32 Billion of taxpayer money goes to the world-class NIH laboratories every year, but if that research and innovation never reaches market, there is no opportunity to make a real impact on real lives. I hope that these Startup Challenges continue to grow and spin-out life-changing technologies that can make a meaningful impact on human health, and we at Oncolinx will do anything we can to see that through.
Sincerely,
Sourav Sinha and the entire Oncolinx team
Rosemarie’s vision and grit in this endeavor is truly unparalleled. She had the resources and the expertise to help any team get over any hurdle or obstacle. She made introductions, refined pitches, made important resources accessible, and recruited some of the most prominent industry partners to give each team every opportunity to succeed. It was amazing to see this kind of commitment because usually in any entrepreneurial endeavor is difficult to navigate and there can be a lot of uncertainty, but much of that was minimized with the help of Rosemarie and her team.
Going forward, we should all look forward to the foundation of many great startups from similar CAI and NIH Startup Challenges. These competitions explore all a previously untapped “treasure trove” of innovation to make an impact on human health. More than $32 Billion of taxpayer money goes to the world-class NIH laboratories every year, but if that research and innovation never reaches market, there is no opportunity to make a real impact on real lives. I hope that these Startup Challenges continue to grow and spin-out life-changing technologies that can make a meaningful impact on human health, and we at Oncolinx will do anything we can to see that through.
Sincerely,
Sourav Sinha and the entire Oncolinx team